Shortage outlook · by company · read 11 November 2026

Which drugs does Amphastar Pharmaceuticals, Inc. have on the FDA shortage list?

Amphastar Pharmaceuticals, Inc. has 6 presentations of 6 drugs on the FDA shortage list, 0 of them reported unavailable. Each is the company's own report to the FDA, with the date of its last update. A report is the company's statement, not a check of any pharmacy's stock.

Not medical advice. A listing is what the FDA published, not a measure of what your pharmacy can supply. Do not use this page to decide whether to start, stop or change a medicine. Ask your pharmacist or prescriber, and see FDA drug shortage information for current notices.

Amphastar Pharmaceuticals, Inc.company reports to the FDA shortage list

6drugs on the list

Amphastar Pharmaceuticals, Inc. has 6 presentations of 6 drugs on the FDA shortage list in 11 November 2026.

The company reported 4 available, 2 with limited availability and 0 unavailable.

Drug by drug, as the company reported it

Atropine Sulfate1 presentation · on the list 12 years and 5 months · last updated 6 November 2026
Dextrose Monohydrate 50% Injection1 presentation · last updated 6 November 2026
Lidocaine Hydrochloride (Xylocaine)1 presentation · on the list 12 years and 5 months · last updated 6 November 2026
Lorazepam1 presentation · on the list 8 years and 6 months · last updated 6 November 2026
Morphine Sulfate1 presentation · on the list 9 years · last updated 6 November 2026
Sodium Bicarbonate1 presentation · on the list 9 years and 8 months · last updated 6 November 2026

FDA current shortage listing file, read 11 November 2026. Availability is the company's own statement to the FDA, not a check of any pharmacy's stock.

Where can you go from here?

Look up any medicine to see how long it has been listed and every company that reports it. The FDA explains what a listing means in the FDA's frequently asked questions about drug shortages, and the list itself is the FDA drug shortages database.